Joe
10-05-2008, 08:40 AM
I recently became aware of a Phase III clinical trial of Myocet. This investigational drug is an encapsulated form of Adriamycin. This drug is currently approved in Europe
It does not have the usual cardiotoxicity associated with AC.
http://clinicaltrials.gov/ct2/show/NCT00294996?term=myocet%2C+sopherion&rank=1
For more drug info:
http://www.cancerbackup.org.uk/Treatments/Chemotherapy/Individualdrugs/Liposomaldoxorubicin
Regards
Joe
It does not have the usual cardiotoxicity associated with AC.
http://clinicaltrials.gov/ct2/show/NCT00294996?term=myocet%2C+sopherion&rank=1
For more drug info:
http://www.cancerbackup.org.uk/Treatments/Chemotherapy/Individualdrugs/Liposomaldoxorubicin
Regards
Joe